Pay in 4 interest-free payments of $6.89 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Lixisenatide has a half-life of only 24 h
The primary endpoint was major adverse cardiovascular events (often called MACE), a combined measure of: Cardiovascular death Nonfatal heart attack Nonfatal stroke Over a median follow-up of about 3.5 years, semaglutide reduced the relative risk of these events by about 20% compared with placebo
Doctors usually weigh the potential benefits against the risks when prescribing Ozempic to someone with ulcerative colitis
After that period, any unused pen must be discarded, even if it appears normal
Exenatide is estimated to lead the drug segment, holding 24.4% share in 2025, reflecting its first-to-market advantage and established clinical profile in certain markets
